mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0087 |
0.8 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
0.0081 |
0.8 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.8 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0088 |
0.8 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.0087 |
0.8 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.8 |
mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.8 |